Spacelabs Healthcare Announces FDA Clearance for U.S. Sale and Distribution of Diagnostic Cardiology Data Management System

HAWTHORNE, CA -- (MARKET WIRE) -- March 07, 2007 -- Spacelabs Healthcare, Inc. (LSE: SLAB), an international medical equipment company listed on the London AIM market, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to distribute in the U.S. its new Cardiology Data Management system, Sentinel.
MORE ON THIS TOPIC